AngioDynamics (ANGO) Tops Q4 EPS by 9c, provides guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.84 +1.08%
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $80.2 million versus the consensus estimate of $74.27 million.
GUIDANCE:
AngioDynamics sees FY2026 EPS of ($0.35)-($0.25), versus the consensus of ($0.23). AngioDynamics sees FY2026 revenue of $305-310 million, versus the consensus of $304.9 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
